Gericare Eye Wash by Kareway Products: Recall—Potential Product Contamination.
AUDIENCE:
Consumer, Pharmacy, Risk Manager
ISSUE:
Kareway Products, Inc is voluntarily recalling 60,000 lots of Gericare Eye Wash, Sterile Eye Irrigation Solution, 4 fluid ounces to the hospital, retail, or consumer level. The product has been found to have potential microbial contamination which compromises sterility. Use of the affected product could be calamitous for any population due to a probability of a potentially sight threatening eye infection or impairment.
BACKGROUND:
The product is used as eye wash to clean, refresh, soothe eyes for daily use or emergency eye cleansing by flushing foreign material. It is packaged in 4 fluid ounce (118 ml) bottles. The affected Gericare Eye Wash, Sterile Eye Irrigation Solution lots include the following Lot#86041601 and expiration date of 09/2019. The product can be identified by UPC 3-57896-18604-3. The product was distributed nationwide to wholesale businesses.
RECOMMENDATION:
Kareway Products is notifying its distributors and customers by recall letter and is arranging for return or disposal of all recalled products. Consumers and businesses that have product which is being recalled should stop using and selling them immediately.
Consumers with questions regarding this recall can contact the Recall Department at 310-532-0009 or recall@kareway.com available Monday through Fridays from 8:30 am to 5:30 pm (Pacific Time). Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.
Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA’s MedWatch Safety Information and Adverse Event Reporting Program.
Click here to read the MedWatch safety alert, along with a link to the press release.
Follow us on Twitter and Facebook for updates on the latest pharmaceutical and biopharmaceutical manufacturing news!
(Source: FDA MedWatch)